Carlier, Paul R.
|Source||US Patent, 6,472,408. Washington, DC: US Patent and Trademark Office, 2002.|
|Summary||The invention relates to dimeric compounds comprising two 5-amino-5,6,7,8-tetrahydroquinoline fragments joined together by a divalent linking group, processes for their preparation, intermediates for their preparation, pharmaceutical compositions containing such dimeric compounds and the use of such compounds as cholinesterase inhibitors and in the treatment of neurodegenerative diseases, such as Alzheimer's Disease and myasthenia gravis.|
View details of TTC.PA.111 via HKUST Technology Transfer Center
Files in this item: